Insulet Corp (NAS:PODD)
$ 200.45 -1.39 (-0.69%) Market Cap: 14.04 Bil Enterprise Value: 14.69 Bil PE Ratio: 60.74 PB Ratio: 17.75 GF Score: 84/100

Insulet Corp at Morgan Stanley Healthcare Conference Transcript

Sep 10, 2019 / 03:45PM GMT
Release Date Price: $146.37 (-0.69%)
David Ryan Lewis
Morgan Stanley, Research Division - MD

Let's go ahead and get started here as we progress through the morning and get into lunch. My name is David Lewis, Medical Device Analyst at Morgan Stanley. It's my pleasure to have with us here Insulet Corporation and 2 members of management, Shacey Petrovic, the CEO; and Wayde McMillan, I was going to say recently hired CFO, but you're actually -- you're almost kind of a veteran now, I feel like.

Wayde D. McMillan
Insulet Corporation - Executive VP,CFO & Treasurer

Yes. 6 months.

Questions & Answers

David Ryan Lewis
Morgan Stanley, Research Division - MD

Almost a veteran. So Shacey, I want to talk sort of strategically, and then I'll go to cut away some other dynamics. But I think the first thing is that the second quarter represented a -- unquestionably, an inflection quarter for Insulet. There's a lot of people kind of calling -- we've had kind of an enormous number of calls about it. What exactly is driving that inflection? So maybe just

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot